Market Overview:
The global alcoholic liver diseases treatment market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of alcoholic liver diseases, rising awareness about available treatments, and growing demand for novel therapies. Based on type, the global alcoholic liver diseases treatment market is segmented into alcoholic fatty liver disease, alcoholic hepatitis, and others. Alcoholic fatty liver disease is estimated to account for the largest share of the global market in 2018. This segment is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030 due to its high prevalence among alcoholics and increasing awareness about its diagnosis and treatment options. Based on application, the global market for alcoholic liver diseases treatment is segmented into hospital pharmacies, retail pharmacies, drug stores, online pharmacies, and others segments such as clinics/hospitals/outpatient settings).
Product Definition:
Alcoholic liver diseases (ALD) are a group of progressive, potentially fatal diseases that develop in people who drink alcohol excessively. The most common ALD is cirrhosis, which is the result of long-term scarring and damage to the liver. Other common ALD include fatty liver disease, alcoholic hepatitis, and esophageal varices. Treatment for ALD focuses on reducing or stopping alcohol consumption, repairing any damage to the liver, and preventing or managing any associated complications.
Alcoholic Fatty Liver Disease:
Alcoholic fatty liver disease (AFLD) is a chronic condition, which causes the accumulation of fat in liver cells. The primary symptoms are steatosis or fat buildup and fibrosis or inflammation of the liver. It may lead to severe complications such as hepatocellular carcinoma (HCC), which is Liver Cancer. According to National Institute of Health, U.S.
Alcoholic Liver Hepatitis:
Alcoholic liver disease (ALD) is a chronic condition, which causes damage to the liver and can result in severe complications if not treated. The most common symptoms include jaundice, fatigue, loss of appetite, nausea and vomiting. According to the National Institute on Alcohol Abuse & Alcoholism (NIAAA), more than 12 million people in the U.
Application Insights:
Based on application, the market is segmented into hospital pharmacies, retail pharmacies, drug stores and online pharmacies. Hospital pharmacy held the largest share in 2017 owing to factors such as high prevalence of patients suffering from ALD at a global level and availability of treatment options for these diseases in hospital settings.
The increasing use of ethanol by individuals consuming drugs or drinking alcohol has resulted in increased incidence rates for these disorders worldwide. In addition, easy accessibility to products such as tablets & capsules makes them more appealing to consumers who are looking forward to get cured soonest possible time with minimum side effects.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the high prevalence of alcoholic liver diseases, increasing awareness about these conditions, and availability of effective treatment options in this region. The U.S., being a developed economy, has a higher penetration rate for modern medicines that are used for treating various liver disorders such as hepatitis and fatty liver disease caused by alcohol consumption.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising disposable income levels among people in emerging economies such as India and China; growing demand for recreational drugs including heroin, cocaine, marijuana; and rise in obesity rates due to westernization of diet along with physical activity levels changing over time (working hours & leisure time). These factors are contributing toward an increase in chronic diseases prevalent among Asian population which is further fueling market growth over the forecast period.
Growth Factors:
- Increasing prevalence of alcoholic liver diseases (ALD) due to changing lifestyles and increasing alcohol consumption.
- Growing awareness about the health risks associated with ALD and its complications.
- Rising number of patients diagnosed with ALD at an early stage due to improved diagnostic techniques.
- Availability of novel treatments for ALD, such as stem cell therapy and gene therapy, that offer better outcomes than traditional treatments options.
Scope Of The Report
Report Attributes
Report Details
Report Title
Alcoholic Liver Diseases Treatment Market Research Report
By Type
Alcoholic Fatty Liver Disease, Alcoholic Liver Hepatitis, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, Others
By Companies
Johnson & Johnson Services, Sanofi, Upsher-Smith Laboratories, Roche Holding, Novartis, GlaxoSmithKline, Pfizer, Bayer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
181
Number of Tables & Figures
127
Customization Available
Yes, the report can be customized as per your need.
Global Alcoholic Liver Diseases Treatment Market Report Segments:
The global Alcoholic Liver Diseases Treatment market is segmented on the basis of:
Types
Alcoholic Fatty Liver Disease, Alcoholic Liver Hepatitis, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson Services
- Sanofi
- Upsher-Smith Laboratories
- Roche Holding
- Novartis
- GlaxoSmithKline
- Pfizer
- Bayer
Highlights of The Alcoholic Liver Diseases Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Alcoholic Fatty Liver Disease
- Alcoholic Liver Hepatitis
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Alcoholic Liver Diseases Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best treatment for alcoholic liver diseases will vary depending on the individual's specific situation and health condition. However, some common treatments for alcoholic liver diseases include:nnu2013 Dietary changes: Some people with alcoholic liver disease find that changing their diet can help improve their symptoms. This may involve reducing or eliminating alcohol consumption, eating a balanced and healthy diet, and taking supplements such as vitamins B12 or B6.nnu2013 Medications: Some people with alcoholic liver disease may need medications to control their symptoms. These medications can include antibiotics or antiviral drugs to fight infection, painkillers to relieve inflammation and pain, and anti-inflammatory drugs such as ibuprofen.
Some of the major companies in the alcoholic liver diseases treatment market are Johnson & Johnson Services, Sanofi, Upsher-Smith Laboratories, Roche Holding, Novartis, GlaxoSmithKline, Pfizer, Bayer.
The alcoholic liver diseases treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Alcoholic Liver Diseases Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Alcoholic Liver Diseases Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Alcoholic Liver Diseases Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Alcoholic Liver Diseases Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Alcoholic Liver Diseases Treatment Market Size & Forecast, 2018-2028
4.5.1 Alcoholic Liver Diseases Treatment Market Size and Y-o-Y Growth
4.5.2 Alcoholic Liver Diseases Treatment Market Absolute $ Opportunity
Chapter 5 Global Alcoholic Liver Diseases Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Alcoholic Liver Diseases Treatment Market Size Forecast by Type
5.2.1 Alcoholic Fatty Liver Disease
5.2.2 Alcoholic Liver Hepatitis
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Alcoholic Liver Diseases Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Alcoholic Liver Diseases Treatment Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Drug Stores
6.2.4 Online Pharmacies
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Alcoholic Liver Diseases Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Alcoholic Liver Diseases Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Alcoholic Liver Diseases Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Alcoholic Liver Diseases Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Alcoholic Liver Diseases Treatment Market Size Forecast by Type
9.6.1 Alcoholic Fatty Liver Disease
9.6.2 Alcoholic Liver Hepatitis
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Alcoholic Liver Diseases Treatment Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Drug Stores
9.10.4 Online Pharmacies
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Alcoholic Liver Diseases Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Alcoholic Liver Diseases Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Alcoholic Liver Diseases Treatment Market Size Forecast by Type
10.6.1 Alcoholic Fatty Liver Disease
10.6.2 Alcoholic Liver Hepatitis
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Alcoholic Liver Diseases Treatment Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Drug Stores
10.10.4 Online Pharmacies
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Alcoholic Liver Diseases Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Alcoholic Liver Diseases Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Alcoholic Liver Diseases Treatment Market Size Forecast by Type
11.6.1 Alcoholic Fatty Liver Disease
11.6.2 Alcoholic Liver Hepatitis
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Alcoholic Liver Diseases Treatment Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Drug Stores
11.10.4 Online Pharmacies
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Alcoholic Liver Diseases Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Alcoholic Liver Diseases Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Alcoholic Liver Diseases Treatment Market Size Forecast by Type
12.6.1 Alcoholic Fatty Liver Disease
12.6.2 Alcoholic Liver Hepatitis
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Alcoholic Liver Diseases Treatment Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Drug Stores
12.10.4 Online Pharmacies
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Alcoholic Liver Diseases Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Alcoholic Liver Diseases Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Alcoholic Liver Diseases Treatment Market Size Forecast by Type
13.6.1 Alcoholic Fatty Liver Disease
13.6.2 Alcoholic Liver Hepatitis
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Alcoholic Liver Diseases Treatment Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Drug Stores
13.10.4 Online Pharmacies
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Alcoholic Liver Diseases Treatment Market: Competitive Dashboard
14.2 Global Alcoholic Liver Diseases Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson & Johnson Services
14.3.2 Sanofi
14.3.3 Upsher-Smith Laboratories
14.3.4 Roche Holding
14.3.5 Novartis
14.3.6 GlaxoSmithKline
14.3.7 Pfizer
14.3.8 Bayer
